| Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic … SL James, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1789-1858, 2018 | 9051 | 2018 |
| Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of … GA Roth, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1736-1788, 2018 | 6874 | 2018 |
| Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study GA Roth, GA Mensah, CO Johnson, G Addolorato, E Ammirati, ... Journal of the American college of cardiology 76 (25), 2982-3021, 2020 | 6399 | 2020 |
| Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and … JD Stanaway, A Afshin, E Gakidou, SS Lim, D Abate, KH Abate, ... The Lancet 392 (10159), 1923-1994, 2018 | 5959* | 2018 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 … HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1859-1922, 2018 | 3932 | 2018 |
| Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 VL Feigin, E Nichols, T Alam, MS Bannick, E Beghi, N Blake, ... The Lancet Neurology 18 (5), 459-480, 2019 | 2485* | 2019 |
| Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 D Dicker, G Nguyen, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1684-1735, 2018 | 976 | 2018 |
| Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 SL James, A Theadom, RG Ellenbogen, MS Bannick, W Montjoy-Venning, ... The Lancet Neurology 18 (1), 56-87, 2019 | 873 | 2019 |
| Global, regional, and national burden of suicide mortality 1990 to 2016: systematic analysis for the Global Burden of Disease Study 2016 M Naghavi bmj 364, 2019 | 866 | 2019 |
| Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic … R Lozano, N Fullman, D Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 2091-2138, 2018 | 508 | 2018 |
| Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global … KR Paulson, AM Kamath, T Alam, K Bienhoff, GG Abady, J Abbas, ... The Lancet 398 (10303), 870-905, 2021 | 322 | 2021 |
| Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 CJL Murray, CSKH Callender, XR Kulikoff, V Srinivasan, D Abate, ... The Lancet 392 (10159), 1995-2051, 2018 | 292 | 2018 |
| Association between obesity and cardiovascular outcomes: a systematic review and meta-analysis of Mendelian randomization studies H Riaz, MS Khan, TJ Siddiqi, MS Usman, N Shah, A Goyal, SS Khan, ... JAMA network open 1 (7), e183788-e183788, 2018 | 292 | 2018 |
| Mapping 123 million neonatal, infant and child deaths between 2000 and 2017 R Burstein, NJ Henry, ML Collison, LB Marczak, A Sligar, S Watson, ... Nature 574 (7778), 353-358, 2019 | 257 | 2019 |
| Empagliflozin, health status, and quality of life in patients with heart failure and preserved ejection fraction: the EMPEROR-Preserved trial J Butler, G Filippatos, T Jamal Siddiqi, M Brueckmann, M Böhm, ... Circulation 145 (3), 184-193, 2022 | 156 | 2022 |
| Sodium-glucose co-transporter 2 inhibitors and cardiovascular outcomes: a systematic review and meta-analysis MS Usman, TJ Siddiqi, MM Memon, MS Khan, WF Rawasia, ... European journal of preventive cardiology 25 (5), 495-502, 2018 | 153 | 2018 |
| Is there a smoker’s paradox in COVID-19? MS Usman, TJ Siddiqi, MS Khan, UK Patel, I Shahid, J Ahmed, A Kalra, ... BMJ evidence-based medicine 26 (6), 279-284, 2021 | 151 | 2021 |
| Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17 A Deshpande, MK Miller-Petrie, PA Lindstedt, MM Baumann, KB Johnson, ... The Lancet Global Health 8 (9), e1162-e1185, 2020 | 144 | 2020 |
| Ten‐year trends in enrollment of women and minorities in pivotal trials supporting recent US food and drug administration approval of novel cardiometabolic drugs MS Khan, I Shahid, TJ Siddiqi, SU Khan, HJ Warraich, SJ Greene, J Butler, ... Journal of the American heart association 9 (11), e015594, 2020 | 127 | 2020 |
| Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial J Butler, SD Anker, LH Lund, AJS Coats, G Filippatos, TJ Siddiqi, T Friede, ... European heart journal 43 (41), 4362-4373, 2022 | 108 | 2022 |
Muhammad Shariq UsmanPhysician, UT Southwestern Medical Center在 UTSouthwestern.edu 的电子邮件经过验证
Muhammad Shariq UsmanPhysician, UT Southwestern Medical Center在 UTSouthwestern.edu 的电子邮件经过验证